Why Peripheral Neuropathy Is on the Rise And What Physicians Need to Know
- johnhayesjr1
- Jul 25
- 1 min read
Peripheral neuropathy is no longer a rare complication. It’s becoming a mainstream clinical challenge. Once primarily linked to advanced diabetes, we now see it emerging across diverse patient populations: younger individuals, those with metabolic syndrome, autoimmune disorders, and even so-called “healthy” adults reporting chronic numbness, burning, and pain.
The Alarming Neuropathy Trends
Recent data suggests:
Over 20 million Americans are affected by peripheral neuropathy.
Many remain undiagnosed for years.
Neuropathy-related visits to primary care and urgent care centers have increased by over 70% in the past decade.
This silent epidemic is fueled by:
Rising rates of prediabetes and insulin resistance.
Chronic micronutrient deficiencies (especially B vitamins).
Medication-induced nerve damage from statins, chemotherapy, and antibiotics.
Post-viral syndromes, including COVID-related neuropathic symptoms.
A Wake-Up Call for Independent Physicians
As independent and direct-pay physicians, we are uniquely positioned to do better. Without the limitations of insurance-based care, we can:
Screen earlier using simple, in-office tools.
Educate patients proactively about metabolic risk and prevention.
Offer non-pharmaceutical strategies that address root causes not just symptoms.
What You Can Do Today
Audit your current patient population for early neuropathy signs.
Start screening all metabolic-risk patients with tools like vibration, monofilament, and temperature testing.
Consider integrating a neuropathy-focused program into your practice.
By taking the lead on this issue, you can fill a care gap your patients are already searching for answers to.
Ready to Differentiate Your Practice?
Reach out to John Hayes Jr., MD to learn how independent physicians are leading the charge in neuropathy care and building thriving practices in the process.
Comments